In the setting of acute myocardial infarction, pre‐treatment with guanabenz (which enhances eIF2α phosphorylation and increases ATF4 levels) largely corrected the deficit in Nox4 KO hearts but had no additional effect in WT hearts. This evidence concerns the gene EIF2A and myocardial infarction.